UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
September 2, 2025
Accession Number:
0001493152-25-012441
Submission Type:
POS AM
CIK:
0001595353
Company Name:
Galmed Pharmaceuticals Ltd.
File Number:
333-289703